bioRxivImmunology
Potential Neutralizing Antibodies Discovered for Novel Corona Virus Using Machine Learning
Abstract
The fast and untraceable virus mutations take lives of thousands of people before the immune system can produce the inhibitory antibody. Recent outbreak of novel coronavirus infected and killed thousands of people in the world. Rapid methods in finding peptides or antibody sequences that can inhibit the viral epitopes of COVID-19 will save the life of thousands. In this paper, we devised a machine learning (ML) model to predict the possible inhibitory synthetic antibodies for Corona virus. We collected 1933 virus-antibody sequences and their clinical patient neutralization response and trained an ML model to predict the antibody response. Using graph featurization with variety of ML methods, we screened thousands of hypothetical antibody sequences and found 8 stable antibodies that potentially inhibit COVID-19. We combined bioinformatics, structural biology, and Molecular Dynamics (MD) simulations to verify the stability of the candidate antibodies that can inhibit the Corona virus.
- assay: protein sequence
- research focus: drug response / drug discovery
- approach: machine learning (classical)
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rapid in silico design of antibodies targeting SARS-CoV-2 using machine learning and supercomputing
Thomas Desautels, Adam T Zemla, … Daniel Faissol·bioRxiv·Apr 3, 2020
- Exploring epitope and functional diversity of anti-SARS-CoV2 antibodies using AI-based methods
Christophe Dumet, Yann Jullian, … Anne Poupon B·bioRxiv·Dec 23, 2020
- High-throughput ML-guided design of diverse single-domain antibodies against SARS-CoV-2
Christof Angermueller, Zelda Mariet, … Lucy J. Colwell·bioRxiv·Dec 1, 2023
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
P. Brouwer, T. Caniels, … M. van Gils·bioRxiv·May 12, 2020
- Rapid selection of a human monoclonal antibody that potently neutralizes SARS-CoV-2 in two animal models
W. Li, A. Drelich, … D. S. Dimitrov·bioRxiv·May 13, 2020
- Cross-neutralization antibodies against SARS-CoV-2 and RBD mutations from convalescent patient antibody libraries